Cargando…

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective

Detalles Bibliográficos
Autores principales:	Abduljalil, Jameel M., Elfiky, Abdo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628894/ https://www.ncbi.nlm.nih.gov/pubmed/36089103 http://dx.doi.org/10.1016/j.jinf.2022.09.002

Ejemplares similares

Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico
por: Abduljalil, Jameel M., et al.
Publicado: (2023)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
por: Sonousi, Amr, et al.
Publicado: (2021)

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
por: Abosheasha, Mohammed A., et al.
Publicado: (2021)

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
por: Elfiky, Abdo A.
Publicado: (2020)

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico
por: Elfiky, Abdo A., et al.
Publicado: (2021)

Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation
por: Gulati, Pallavi, et al.
Publicado: (2023)

Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach
por: Sahu, Anshuman, et al.
Publicado: (2023)

Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight
por: Begum, Feroza, et al.
Publicado: (2021)

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective
por: Ogunyemi, Oludare M, et al.
Publicado: (2020)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
por: Gangadharan, Sivakumar, et al.
Publicado: (2022)

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
por: Elfiky, Abdo A.
Publicado: (2020)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico
por: Elfiky, Abdo A, et al.
Publicado: (2021)

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]
por: Elfiky, Abdo A.
Publicado: (2020)

Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view
por: Elfiky, Abdo A, et al.
Publicado: (2022)

Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
por: Vuorio, Alpo, et al.
Publicado: (2022)

How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics?
por: Abduljalil, Jameel M., et al.
Publicado: (2023)

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective
por: Elgohary, Alaa M., et al.
Publicado: (2021)

Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
por: Watashi, Koichi
Publicado: (2021)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022)

Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
por: Sekaran, Saravanan, et al.
Publicado: (2023)

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
por: Elfiky, Abdo A., et al.
Publicado: (2016)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach
por: Altayb, Hisham N.
Publicado: (2022)

Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
por: Shahabadi, Nahid, et al.
Publicado: (2023)

Repurposing existing drugs for monkeypox: applications of virtual screening methods
por: Li, Vladimir, et al.
Publicado: (2023)

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease
por: Bhattacharjee, Arittra, et al.
Publicado: (2022)

A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus
por: Alandijany, Thamir A., et al.
Publicado: (2023)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
por: Xu, Eric, et al.
Publicado: (2023)

Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA‐dependent RNA polymerase using molecular modeling approach
por: Dutt, Mansi, et al.
Publicado: (2023)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective
por: Elshemey, Wael M., et al.
Publicado: (2022)

Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
por: Ajmal, Amar, et al.
Publicado: (2023)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

In-silico primer designing and PCR for detection of monkeypox virus (MPXV)
por: Khoo, Ying Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4v87lvmotn59tfbim4qobbki54